What is the appropriate treatment for eczema of the nasal folds?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Eczema in the Nasal Folds

For eczema affecting the nasal folds, use a low-potency topical corticosteroid (hydrocortisone 1–2.5% cream) applied twice daily for 2–4 weeks, combined with liberal emollient therapy, because the facial skin—particularly around the nose—is thin and highly susceptible to steroid-induced atrophy. 1

Why Low-Potency Steroids Are Essential for This Location

  • The nasal fold area has uniquely thin skin that makes it prone to corticosteroid-induced atrophy, telangiectasia, and other adverse effects when potent or very potent steroids are used 1
  • Hydrocortisone 1–2.5% delivers sufficient anti-inflammatory activity while minimizing the risk of skin thinning in this sensitive facial region 1
  • Potent or very potent corticosteroids must be avoided in thin-skinned areas including the face, neck, and flexures where atrophy risk is highest 1

Application Strategy

  • Apply the low-potency corticosteroid no more than twice daily to affected nasal fold areas 2
  • Limit continuous application to 2–4 weeks maximum, then implement "steroid holidays" or step down to maintenance therapy 1
  • After initial clearance, consider proactive maintenance with the same low-potency steroid applied twice weekly to previously involved skin to prevent recurrence 1, 3

Essential Adjunctive Emollient Therapy

  • Apply emollients liberally and frequently to the nasal fold area, even when eczema appears controlled, because they restore barrier function and reduce the need for steroids 1, 4
  • Apply emollients immediately after bathing or face-washing to create a surface lipid film that limits transepidermal water loss 2, 1
  • Use soap-free cleansers and avoid alcohol-containing products on the face, as regular soaps strip natural lipids and worsen barrier dysfunction 1

Watch for Secondary Infection

  • Monitor for crusting, weeping, or pustules in the nasal folds, which indicate secondary bacterial infection (most commonly Staphylococcus aureus) 2, 1
  • If bacterial infection is confirmed, prescribe oral flucloxacillin (or erythromycin for penicillin allergy) while continuing the topical corticosteroid—do not withhold steroids during appropriate antibiotic therapy 1, 5
  • Be alert for grouped vesicles or punched-out erosions, which suggest eczema herpeticum (a medical emergency requiring immediate oral or IV acyclovir) 2, 1

Managing Pruritus

  • For nighttime itching that disrupts sleep, prescribe sedating antihistamines (hydroxyzine or diphenhydramine) at bedtime, understanding their benefit is purely sedative rather than antipruritic 1
  • Do not prescribe non-sedating antihistamines, as they have no proven benefit in atopic eczema 1

Common Pitfalls to Avoid

  • Never use potent or very potent corticosteroids on the nasal folds—this thin facial skin will develop atrophy, telangiectasia, and other irreversible changes 1, 6
  • Do not apply topical corticosteroids continuously without breaks; implement regular "steroid holidays" to reduce adverse effects 2, 1
  • Address "steroid phobia" directly by educating patients that low-potency topical corticosteroids (hydrocortisone 1–2.5%) are safe for facial use when applied correctly, to prevent undertreatment 1
  • Keep fingernails short to minimize skin trauma from scratching 2

When to Escalate or Refer

  • If the nasal fold eczema does not respond to low-potency topical corticosteroids after 4 weeks of appropriate use, refer to dermatology 1
  • Refer immediately if eczema herpeticum is suspected (grouped vesicles, punched-out erosions, systemic symptoms) 1
  • Consider dermatology consultation for atypical presentations or diagnostic uncertainty 1

References

Guideline

Treatment of Eczema (Atopic Dermatitis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of Eczema: Corticosteroids and Beyond.

Clinical reviews in allergy & immunology, 2016

Research

A Comprehensive Review of the Treatment of Atopic Eczema.

Allergy, asthma & immunology research, 2016

Guideline

Treatment of Nummular Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What treatment should I prescribe for an adult with an acute eczema flare and no known contraindications?
What is the best approach to managing eczema in the lower eye area?
What is the recommended management for eczema of the neck?
What are the best strategies to prevent recurrent infections in a patient with a history of eczema?
What is the best treatment approach for a patient with dry skin and eczema on the face, experiencing burning and itching sensations?
How should I adjust levothyroxine (Synthroid) dose in an elderly woman taking 112 µg daily with elevated thyroid‑stimulating hormone?
What is the best medication for anxiety in an otherwise healthy adult with generalized anxiety disorder?
In an 84‑year‑old male weighing 150 lb, two months post‑operative and NPO, how much Jevity 1.5 (1.5 kcal/mL) should be given via gastrostomy tube per day and how much additional water is required if he receives ice chips 60 mL five times daily?
What are the typical metastatic sites and pattern of spread for endometrial cancer?
What is the safest evidence‑based first‑line medication for treating hypersexual (disinhibited sexual) behavior in older adults with dementia?
In a 52‑year‑old patient with peripheral edema, macrocytosis (MCV 101 fL), mildly elevated aspartate aminotransferase (AST 124 U/L) and alanine aminotransferase (ALT 71 U/L), fasting glucose 136 mg/dL, severe vitamin D deficiency (25‑hydroxy‑vitamin D 14 ng/mL), mild dyslipidemia (total cholesterol 222 mg/dL, HDL 114 mg/dL, LDL 93 mg/dL), normal renal function, normal albumin, normal thyroid function, and low B‑type natriuretic peptide (BNP 3 pg/mL), what are the most likely contributors to the edema and what initial evaluation and management steps should be taken?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.